Sintilimab Plus Rituximab Followed by R-CHOP Regimen in Untreated PMBL

Clinical trial NCT06742502 · RECRUITING

Trial details

NCT number: NCT06742502
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Mediastinal Diffuse Large B-cell Lymphoma

Start date: 2024-11-12
Primary completion: 2027-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.